Search Medical Condition
Please enter condition
Please choose location
Clear Trial Filters

Krakow, Poland Clinical Trials

A listing of Krakow, Poland clinical trials actively recruiting patients volunteers.

RESULTS

Found (19) clinical trials

This is an investigational Birth Control study for healthy female volunteers ages 16-50

Phase N/A

This is an investigational Zika prevention vaccine for healthy adults ages 18-49 years. For more information, please visit www.optimalsites.net/zika

Phase

This is an pain study following bunionectomies for individuals ages 18 and older. For more information, please visit http://www.optimalsites.net/bunions

Phase

All enrolled subjects must be 18 to 75 years of age. To be enrolled, he or she must also have a history of recurrent herpes labialis (cold sores) and report recurrences during the preceding 12 months. For more information, please visit www.optimalsites.net/coldsore

Phase

A single ascending dose study of the safety and immunogenicity of NasoVAX. An intranasal flu vaccine  

Phase

Eosinophilic esophagitis (EoE) is an inflammatory disease of the esophagus, characterized by eosinophilic infiltration and gastrointestinal symptoms. Swallowed, topically acting corticosteroids, such as fluticasone, appear to be effective in resolving acute clinical and pathological features of EoE. APT-1011 is an orally disintegrating tablet (ODT) formulation of fluticasone propionate. This study ...

Phase

Study for Pediatric ADHD Learning that your [4 to 12] [4 or 5] year old child has attention-deficit/hyperactivity disorder (ADHD) is challenging. It may leave you wondering what options are available for your child and whether they will be safe for your child at such a young age. New clinical ...

Phase N/A

CRT implant strategy using the longest electrical delay for non-left bundle branch block patients (Enhance CRT). 

Phase N/A

A double blind placebo controlled study to evaluate the effects of bexagliflozin on hemoglobin A1c in patients with type 2 diabetes and increased risk of cardiovascular adverse events

Phase